-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Selects Johnson & Johnson's Tecvayli Plus Darzalex Faspro for Priority Review in Multiple Myeloma

路透·12/15/2025 22:40:43

登錄查看新聞詳情